World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
33380
World Ranking
756
National Ranking
430

Medicine

D-Index
99
Citations
33380
World Ranking
8645
National Ranking
4457

Susan Zolla-Pazner publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Susan Zolla-Pazner sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 392 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Susan Zolla-Pazner D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Susan Zolla-Pazner sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Susan Zolla-Pazner is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research focuses primarily on the fields of Medicine and Immunology and Microbiology, with a notable emphasis on Infectious Diseases and Virology. The scientist's work also covers Immunology as well as Radiology, Nuclear Medicine and Imaging, and Molecular Biology.

The main topics addressed in their research include:

  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • Monoclonal and Polyclonal Antibodies Research
  • COVID-19 Impact on Reproduction
  • Infant Nutrition and Health

Frequent publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Nature Communications
  • Journal of Virology
  • iScience

Susan Zolla-Pazner has collaborated regularly with several coauthors, including:

  • Catarina E. Hioe
  • Fatima Amanat
  • Jéromine Klingler
  • Benhur Lee
  • Chitra Upadhyay

Representative papers published by Susan Zolla-Pazner include:

  • "Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk," 2020, iScience
  • "Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19," 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • "Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2," 2020, The Journal of Infectious Diseases
  • "Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera," 2021, mBio
  • "Role of IgM and IgA Antibodies to the Neutralization of SARS-CoV-2," 2020, bioRxiv (Cold Spring Harbor Laboratory)

Susan Zolla-Pazner was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2011.

Best Publications

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

    Robert C. Gallo;Prem S. Sarin;E. P. Gelmann;Marjorie Robert-Guroff

  • Disseminated Kaposi's Sarcoma in Homosexual Men

    ALVlN E. Friedman-Kien;Linda J. Laubenstein;Pablo Rubinstein;Elena Buimovici-Klein

  • Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

    James M. Binley;Terri Wrin;Bette Korber;Michael B. Zwick

  • Mycobacterium avium-intracellulare: A Cause of Disseminated Life-Threatening Infection in Homosexuals and Drug Abusers

    Jeffrey B. Greene;Gurdip S. Sidhu;Sharon Lewin;Jerome F. Levine

  • Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

    Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp

  • A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.

    Hamilton Jd;Hartigan Pm;Simberkoff Ms;Day Pl

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • Immunologic abnormalities in homosexual men: Relationship to Kaposi's sarcoma

    Rosalyn E. Stahl;Alvin Friedman-Kien;Ronald Dubin;Michael Marmor

  • Identifying epitopes of HIV-1 that induce protective antibodies.

    Susan Zolla-Pazner

  • Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1

    A Pinter;W J Honnen;S A Tilley;C Bona

  • Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.

    M K Gorny;A J Conley;S Karwowska;A Buchbinder

  • Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    Young Do Kwon;Marie Pancera;Priyamvada Acharya;Ivelin S. Georgiev

  • The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection.

    Abraham Pinter;William J. Honnen;Yuxian He;Miroslaw K. Gorny

  • Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    Allan deCamp;Peter Hraber;Robert T. Bailer;Michael S. Seaman

  • Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.

    M. K. Gorny;Jian-Yin Xu;S. Karwowska;A. Buchbinder

  • Association of human immunodeficiency virus infection and autoimmune phenomena

    Rima G. Kopelman;Rima G. Kopelman;Susan Zolla-Pazner;Susan Zolla-Pazner

  • Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

    Susan Zolla-Pazner;Allan DeCamp;Peter B. Gilbert;Constance Williams

  • Epitope exposure on functional, oligomeric HIV-1 gp41 molecules.

    Quentin J. Sattentau;Susan Zolla-Pazner;Pascal Poignard

  • Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

    Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham

  • Generation of human monoclonal antibodies to human immunodeficiency virus

    Miroslaw K. Gorny;Vasiliki Gianakakos;Sandra Sharpe;Susan Zolla-Pazner

Frequent Co-Authors

Miroslaw K. Gorny
Miroslaw K. Gorny New York University
Abraham Pinter
Abraham Pinter Rutgers, The State University of New Jersey
David C. Montefiori
David C. Montefiori Duke University
Barton F. Haynes
Barton F. Haynes Duke University
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
John R. Mascola
John R. Mascola ModeX Therapeutics
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Shan Lu
Shan Lu University of Massachusetts Chan Medical School
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
Jerome H. Kim
Jerome H. Kim Walter Reed Army Institute of Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology opens doors to a variety of healthcare careers, many of which can be pursued through online education. For those looking to transition into nursing from a different field, an online ABSN programs for non nurses offer an accelerated path to becoming a registered nurse.

Once in nursing, professionals may choose to specialize further. Enrolling in an accelerated NP program can fast-track the journey to becoming a nurse practitioner, a role often involved in immunology-related diagnostics and treatment.

For those seeking foundational nursing credentials, identifying the easiest ABSN to get into can make entry into the field more accessible. Similarly, starting as a licensed practical nurse through LPN programs easy to get into allows learners to build clinical experience that supports future specialization in immunology or related healthcare fields.

Choosing the right online program aligned with career goals can greatly enhance opportunities in immunology and healthcare. These pathways offer flexibility and options tailored to diverse backgrounds and professional aspirations.

Best Scientists Citing Susan Zolla-Pazner

Trending Scientists

Recently Published Articles